SU510986A3 - Способ получени раствора окситетрациклина - Google Patents

Способ получени раствора окситетрациклина

Info

Publication number
SU510986A3
SU510986A3 SU1158241A SU1158241A SU510986A3 SU 510986 A3 SU510986 A3 SU 510986A3 SU 1158241 A SU1158241 A SU 1158241A SU 1158241 A SU1158241 A SU 1158241A SU 510986 A3 SU510986 A3 SU 510986A3
Authority
SU
USSR - Soviet Union
Prior art keywords
solution
oxytetracycline
water
solutions
magnesium
Prior art date
Application number
SU1158241A
Other languages
English (en)
Russian (ru)
Inventor
Антониус Вебер Хуберт
Питер Моленаар Андрианус
Original Assignee
Конинклике Нидерландше Гистен Спиритусфабрик Н.В. (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Конинклике Нидерландше Гистен Спиритусфабрик Н.В. (Фирма) filed Critical Конинклике Нидерландше Гистен Спиритусфабрик Н.В. (Фирма)
Application granted granted Critical
Publication of SU510986A3 publication Critical patent/SU510986A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SU1158241A 1966-05-31 1967-05-25 Способ получени раствора окситетрациклина SU510986A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (US20050137174A1-20050623-C00027.png) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
SU510986A3 true SU510986A3 (ru) 1976-04-15

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1158241A SU510986A3 (ru) 1966-05-31 1967-05-25 Способ получени раствора окситетрациклина

Country Status (22)

Country Link
US (1) US3557280A (US20050137174A1-20050623-C00027.png)
JP (1) JPS5010373B1 (US20050137174A1-20050623-C00027.png)
AT (1) AT272522B (US20050137174A1-20050623-C00027.png)
BE (1) BE699091A (US20050137174A1-20050623-C00027.png)
CH (1) CH490087A (US20050137174A1-20050623-C00027.png)
CS (1) CS151454B2 (US20050137174A1-20050623-C00027.png)
DE (1) DE1617576C3 (US20050137174A1-20050623-C00027.png)
DK (1) DK117587B (US20050137174A1-20050623-C00027.png)
ES (1) ES340956A1 (US20050137174A1-20050623-C00027.png)
FI (1) FI43622B (US20050137174A1-20050623-C00027.png)
FR (1) FR5953M (US20050137174A1-20050623-C00027.png)
GB (1) GB1131007A (US20050137174A1-20050623-C00027.png)
GR (1) GR33861B (US20050137174A1-20050623-C00027.png)
IL (1) IL28009A (US20050137174A1-20050623-C00027.png)
IT (1) IT1140250B (US20050137174A1-20050623-C00027.png)
LU (1) LU53788A1 (US20050137174A1-20050623-C00027.png)
MY (1) MY7100015A (US20050137174A1-20050623-C00027.png)
NL (1) NL6607516A (US20050137174A1-20050623-C00027.png)
NO (1) NO126298B (US20050137174A1-20050623-C00027.png)
SE (1) SE354417B (US20050137174A1-20050623-C00027.png)
SU (1) SU510986A3 (US20050137174A1-20050623-C00027.png)
YU (1) YU31326B (US20050137174A1-20050623-C00027.png)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (US20050137174A1-20050623-C00027.png) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
DK1240133T3 (da) 1999-09-14 2006-08-21 Tufts College Fremgangsmåde til fremstilling af substituerede tetracycliner med overgangsmetalbaserede kemiske metoder
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
WO2001052858A1 (en) * 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
JP2004505012A (ja) 2000-03-31 2004-02-19 トラスティーズ・オブ・タフツ・カレッジ 7−および9−カルバメート、尿素、チオ尿素、チオカルバメート、およびヘテロアリール−アミノ置換テトラサイクリン化合物
DE60102815D1 (de) * 2000-05-15 2004-05-19 Paratek Pharm Innc 7-substituierte kondensierte ring-tetrazyclin- verbindungen
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
DE60144375D1 (de) 2000-07-07 2011-05-19 Trustees Of Tufts College Medford 7-, 8- und 9-substitutierte tetracyclinverbindungen
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
HUP0301163A3 (en) * 2000-07-07 2008-08-28 Tufts College 7-substituted tetracycline dervatives, pharmaceutical compositions containing them and their use
US6846939B2 (en) 2000-07-07 2005-01-25 Paratek Pharmaceuticals, Inc. 9-substituted minocycline compounds
CA2415172A1 (en) 2000-07-07 2002-01-17 Mark L. Nelson 13-substituted methacycline compounds
IL157860A0 (en) 2001-03-13 2004-03-28 Paratek Pharm Innc 7,9-substituted tetracycline compounds
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
CA2457234A1 (en) * 2001-03-14 2002-09-19 Mark L. Nelson Substituted tetracycline compounds as antifungal agents
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
DE60235083D1 (de) 2001-04-24 2010-03-04 Paratek Pharm Innc Substituierte tetracyclin-verbindungen zur behandlung von malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2311798A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EA200802365A1 (ru) 2002-03-08 2009-08-28 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
IL164180A0 (en) 2002-03-21 2005-12-18 Paratek Pharm Innc Substituted tetracycline compounds
WO2004006850A2 (en) 2002-07-12 2004-01-22 Paratek Pharmaceuticals, Inc 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
EP1556007A4 (en) 2002-10-24 2008-12-17 Paratek Pharm Innc SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA
EP1605916A4 (en) * 2003-02-12 2012-02-22 R & P Korea Co Ltd SOLUBENT SOLVENT SYSTEM WITH SOLUBLE PEEL WITH IMPROVED ELUTION RATE
WO2005009943A2 (en) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド 9−アミノメチルテトラサイクリン化合物のプロドラッグ
CA2553510C (en) 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
CA2585418A1 (en) * 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2949644A3 (en) 2004-10-25 2016-04-20 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2597212A1 (en) * 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
JP2009508951A (ja) * 2005-09-19 2009-03-05 アルベマール・コーポレーシヨン カリウムイブプロフェンの極めて濃厚な注入可能な水溶液、その製造法および使用
WO2007087416A2 (en) * 2006-01-24 2007-08-02 Paratek Pharaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
CA2649221A1 (en) * 2006-04-17 2007-10-25 Evgeny Tsiperman Isolation of tetracycline derivatives
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
EP2016045B1 (en) * 2006-04-24 2014-10-29 Teva Pharmaceutical Industries, Ltd. A tigecycline crystalline form and processes for its preparation
CA2652346A1 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
PT2120963T (pt) 2006-12-21 2018-12-17 Paratek Pharm Innc Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
US8318706B2 (en) 2006-12-21 2012-11-27 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
JP2010523684A (ja) 2007-04-12 2010-07-15 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物を用いる、脊髄筋委縮症を治療するための方法
CA2688662A1 (en) 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
ATE555079T1 (de) 2007-07-06 2012-05-15 Paratek Pharm Innc Verfahren zur synthese von 9-substituiertem minocyclin
CN102015602A (zh) 2008-03-05 2011-04-13 帕拉特克药品公司 米诺环素化合物及其使用方法
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
AU2009236631A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202216656A (zh) 2008-05-23 2022-05-01 美商Prtk Spv2公司 四環素化合物之甲苯磺酸鹽及同素異形體
US9629806B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
KR20110081197A (ko) * 2008-09-19 2011-07-13 파라테크 파마슈티컬스, 인크. 류마티스 관절염의 치료를 위한 테트라시클린 화합물 및 관련된 치료 방법
CA2758322C (en) 2009-04-10 2019-04-02 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
EP3574908A1 (en) 2011-05-12 2019-12-04 Paratek Pharmaceuticals, Inc. Crystalline salts of (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2carboxylic acid amide and methods of using the same
SG11201903846TA (en) 2016-11-01 2019-05-30 Paratek Pharm Innc 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
CA3070663A1 (en) 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions

Also Published As

Publication number Publication date
FR5953M (US20050137174A1-20050623-C00027.png) 1968-04-16
GB1131007A (en) 1968-10-16
YU31326B (en) 1973-04-30
SE354417B (US20050137174A1-20050623-C00027.png) 1973-03-12
GR33861B (el) 1968-02-09
DE1617576B2 (de) 1980-04-10
ES340956A1 (es) 1968-06-16
DE1617576C3 (de) 1980-12-11
DK117587B (da) 1970-05-11
CS151454B2 (US20050137174A1-20050623-C00027.png) 1973-10-19
BE699091A (US20050137174A1-20050623-C00027.png) 1967-11-27
LU53788A1 (US20050137174A1-20050623-C00027.png) 1967-07-31
CH490087A (de) 1970-05-15
FI43622B (US20050137174A1-20050623-C00027.png) 1971-02-01
IT1140250B (it) 1986-09-24
JPS5010373B1 (US20050137174A1-20050623-C00027.png) 1975-04-21
DE1617576A1 (de) 1972-04-27
NO126298B (US20050137174A1-20050623-C00027.png) 1973-01-22
NL6607516A (US20050137174A1-20050623-C00027.png) 1967-12-01
US3557280A (en) 1971-01-19
IL28009A (en) 1970-08-19
AT272522B (de) 1969-07-10
MY7100015A (en) 1971-12-31

Similar Documents

Publication Publication Date Title
SU510986A3 (ru) Способ получени раствора окситетрациклина
US9457020B2 (en) Liquid pharmaceutical formulations of palonosetron
US3674859A (en) Aqueous doxycycline compositions
KR19990063978A (ko) 안정한 파라세타몰 기재 액체 제형 및 이들을 제조하기 위한방법
RU2000121254A (ru) Лекарственные препараты
RU2002106399A (ru) Составы моксифлоксацина, содержащие поваренную соль
ES2287658T3 (es) Composiciones inyectables estables de diclofenac.
MX2007004490A (es) Composiciones que contienen piperacilina, tazobactam y un acido aminocarboxilico en un diluyente de lactato de sodio.
US3957972A (en) Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
US9439854B2 (en) Liquid pharmaceutical formulations of palonosetron
RU2006126708A (ru) Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применения
SU1072789A3 (ru) Способ получени соли стероида дл парентерального введени
JPS5914447B2 (ja) pHおよび色安定化非経口投与用水性抗性物質組成物
US3969524A (en) Stable amoxicillin dosage form
AU5409201A (en) Solution of N-(O-(p-pivaloyloxy benzene sulfonylamino) benzoyl)glycine monosodium salt tetra-hydrate and drug product thereof
CN1228053C (zh) 含有二尿苷磷酸的滴眼液
US4301160A (en) Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide and process for their preparation
US4088759A (en) Injectable pharmaceutical solutions
NO168375B (no) Fremgangsmaate for delignifisering av celluloseholdig materiale
KR840001508B1 (ko) 즉시 사용할 수 있는 주사용 수용액의 제조방법
RU2118156C1 (ru) Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для инъекций
RU2031650C1 (ru) Противовирусное лекарственное средство и способ его получения
RU2076710C1 (ru) Лекарственное средство для лечения опухолевых заболеваний
RU1819613C (ru) Способ получени антиглаукомного средства
PL63089B1 (US20050137174A1-20050623-C00027.png)